In this week's episode, Estimize is joined by Joe McCann, a former biotech analyst at CR Intrinsic and the CEO of Slingshot Insights.
In the episode, Joe discusses Biogen Inc BIIB new drug, which could be the holy grail for biotech stocks. Leigh and Joe also chat about a hedge fund that seeks to make drug prices cheaper, and wrap things up with a complete earnings overview for the biotech sector.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in